Candel Therapeutics Stock News & Updates

[WKN: A3CVW2 | Symbol: CADL]
Candel Therapeutics

Candel Therapeutics: Compelling Clinical Phase 3 Data and a $22 Price Target by Stifel!

Analysts' top 5 price targets on February 07, 2025

Klöckner & Co. [DE000KC01000]: Kepler Cheuvreux initiates coverage with a Buy rating and a price...

  • ‹
  • 1
  • ›